Target type: biologicalprocess
Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion. [GOC:ai]
Intracellular pH reduction is a complex biological process that involves the movement of protons (H+) across cellular membranes. It is crucial for maintaining cellular homeostasis and is involved in various physiological functions, including:
- **Regulation of enzyme activity:** Many enzymes have optimal pH ranges, and pH changes can alter their activity.
- **Signal transduction:** pH changes can act as signaling molecules, triggering downstream pathways.
- **Protein folding and stability:** pH influences the folding and stability of proteins, which can impact their function.
- **Cellular metabolism:** pH gradients are critical for driving various metabolic reactions, such as ATP production.
**Mechanisms of intracellular pH reduction:**
- **Proton pumps:** These transmembrane proteins actively transport protons out of the cell, lowering intracellular pH. Examples include the Na+/H+ exchanger (NHE) and the vacuolar H+-ATPase (V-ATPase).
- **Carbon dioxide (CO2) production:** Metabolic processes such as glycolysis and oxidative phosphorylation generate CO2, which can be converted to carbonic acid (H2CO3) and then to bicarbonate (HCO3-) and protons.
- **Metabolic acid production:** Metabolic pathways, like anaerobic glycolysis, produce organic acids (e.g., lactic acid) that contribute to acidification.
- **Leakage of protons:** Imperfections in the cell membrane can lead to leakage of protons into the cell.
**Regulation of intracellular pH:**
- **Buffering systems:** Cells contain buffering systems, such as proteins and bicarbonate, that help to resist changes in pH.
- **pH sensors:** Cells possess sensors that detect pH changes and activate signaling pathways to restore pH homeostasis.
- **Compensation mechanisms:** If pH drops too low, cells can activate mechanisms to increase pH, such as increasing proton extrusion or reducing acid production.
**Disruption of intracellular pH homeostasis:**
- **Metabolic disorders:** Conditions like diabetes and lactic acidosis can disrupt pH balance.
- **Cellular stress:** Exposure to toxins, hypoxia, and other stressors can lead to pH changes.
- **Disease states:** Cancer cells often exhibit altered pH regulation.
**Conclusion:**
Intracellular pH reduction is a vital process that is tightly regulated to maintain cellular function. Its disruption can have severe consequences for cell health and disease development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Solute carrier family 12 member 5 | A solute carrier family 12 member 5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H2X9] | Homo sapiens (human) |
V-type proton ATPase subunit S1 | A V-type proton ATPase subunit S1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15904] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
bafilomycin a1 | bafilomycin A1 : The most used of the bafilomycins, a family of toxic macrolide antibiotics derived from Streptomyces griseus. bafilomycin A1: from Streptomyces griseus; structure given in first source | cyclic hemiketal; macrolide antibiotic; oxanes | apoptosis inducer; autophagy inhibitor; bacterial metabolite; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor; ferroptosis inhibitor; fungicide; potassium ionophore; toxin |
n-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide | N-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-ylthio)acetamide: a KCC2 cotransporter antagonist | pyridazines; ring assembly |